Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALPI | P09923 | 1/20 | 0.58 |
| ▸ | PKM | P14618 | 1/20 | 0.58 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.58 |
| ▸ | XIAP | P98170 | 1/20 | 0.58 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.58 |
| ▸ | SLC15A1 | P46059 | 2/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.48 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.48 |
| ▸ | MAOA | P21397 | 1/20 | 0.48 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.48 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.48 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.48 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.48 |
| ▸ | ANPEP | P15144 | 2/20 | 0.48 |
| ▸ | RNPEP | Q9H4A4 | 2/20 | 0.48 |
| ▸ | DNPEP | Q9ULA0 | 2/20 | 0.48 |
| ▸ | LTA4H | P09960 | 2/20 | 0.47 |
| ▸ | CTRB1 | P17538 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8835936 | 0.91 | SLC7A5 (0.68) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL288607 | 0.91 | SLC7A5 (0.68) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL28820471 | 0.91 | SLC7A5 (0.68) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL29160724 | 0.90 | SLC7A5 (0.66) | ALPIPKMPTGS1XIAPSLC7A5 | |
| Tyrosine SCHEMBL2284684 | 0.89 | SLC7A5 (0.63) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL27978089 | 0.89 | ALPI (0.56) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL1679191 | 0.87 | ALPI (0.54) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL27978358 | 0.87 | ALPI (0.54) | ALPIPKMPTGS1XIAPSLC7A5 | |
| Hydrochloric Acid SCHEMBL27978312 | 0.87 | ALPI (0.54) | ALPIPKMPTGS1XIAPSLC7A5 | |
| SCHEMBL208390 | 0.87 | ANPEP (0.57) | ALPIPKMPTGS1XIAPSLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115896059-A | Cyclodextrin glycosyltransferase mutant for preparing rebaudioside RM, coding gene and application thereof | 三元生物工程研究(天津)有限公司 | 2023-04-04 | — | — | CN | claimed |
| CN-107667293-A | Diagnostic tool for Ah Hereby sea Mo's disease | 法奈科斯公司 | 2018-02-06 | — | — | CN | claimed |
| US-20100041612-A1 | Fragments of the Glucagon-Like Peptide-1 and Uses Thereof | NEW ENGLAND MEDICAL CENTER HOSPITALS, INC. | 2010-02-18 | — | — | US | claimed |
| US-20090105134-A1 | C-Terminally Pegylated Growth Hormones | NOVO NORDISK A/S (DK) | 2009-04-23 | — | — | US | claimed |
| WO-2007030706-A1 | FRAGMENTS OF THE GLUCAGON-LIKE PEPTIDE-I AND USES THEREOF | NEW ENGLAND MEDICAL CENTER HOSPITALS, INC. (US) | 2007-03-15 | — | — | WO | claimed |
| EP-0226304-B1 | COMPOSITION CONTAINING A PENEM OR CARBAPENEM ANTIBIOTIC | SANKYO COMPANY LIMITED (JP) | 1991-08-28 | — | — | EP | claimed |
| CN-117551032-A | Drug conjugates comprising quinoline derivatives | 国家科学研究中心 | 2024-02-13 | — | — | CN | disclosed |
| CN-112955434-B | Drug conjugates comprising quinoline derivatives | 国家科学研究中心 | 2023-12-08 | — | — | CN | disclosed |
| WO-2023224577-A1 | INHALATION COMPOSITIONS COMPRISING MICRONIZED HUMAN INSULIN | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi (TR) | 2023-11-23 | — | — | WO | disclosed |
| CN-112094856-B | Transaminase mutant and application thereof in sitagliptin synthesis | 国药集团威奇达药业有限公司 | 2023-06-27 | — | — | CN | disclosed |
| CN-116162562-A | Lactobacillus delbrueckii subspecies and culture method and application thereof | 深圳市盐田区人民医院 | 2023-05-26 | — | — | CN | disclosed |
| CN-114164134-B | Bifidobacterium longum subspecies longum with functions of preventing and relieving colitis symptoms and application thereof | 东北农业大学 | 2023-03-03 | — | — | CN | disclosed |
| CN-114667298-A | SIGLEC-9ECD fusion molecules and methods of use thereof | 艾利妥 | 2022-06-24 | — | — | CN | disclosed |
| EP-1465908-A4 | COMPOSITIONS AND METHODS FOR HYDROXYLATING EPOTHILONES | BRISTOL MYERS SQUIBB CO (US) | 2005-11-30 | — | — | EP | disclosed |
| EP-1572991-A2 | COMPOSITIONS AND METHODS FOR HYDROXILATING EPOTHILONES | Bristol-Myers Squibb Company (US) | 2005-09-14 | — | — | EP | disclosed |
| EP-1465908-A2 | COMPOSITIONS AND METHODS FOR HYDROXYLATING EPOTHILONES | Bristol-Myers Squibb Company (US) | 2004-10-13 | — | — | EP | disclosed |
| WO-2004078978-A1 | COMPOSITIONS AND METHODS FOR HYDROXYLATING EPOTHILONES | BRISTOL-MYERS SQUIBB COMPANY (US) | 2004-09-16 | — | — | WO | disclosed |
| WO-2004061116-A2 | COMPOSITIONS AND METHODS FOR HYDROXILATING EPOTHILONES | BRISTOL-MYERS SQUIBB COMPANY (US) | 2004-07-22 | — | — | WO | disclosed |
| WO-2003057830-A2 | COMPOSITIONS AND METHODS FOR HYDROXYLATING EPOTHILONES | BRISTOL-MYERS SQUIBB COMPANY (US) | 2003-07-17 | — | — | WO | disclosed |
| WO-1993005011-A1 | NOVEL IMMUNOSUPPRESSANTS | SANDOZ LTD. (CH) | 1993-03-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090105134-A1 | C-Terminally Pegylated Growth Hormones | GHRHR, GHITM, HDGF | ALPI 2242/4885PKM 4447/4885PTGS1 3835/4885 |
| US-20100041612-A1 | Fragments of the Glucagon-Like Peptide-1 and Uses Thereof | GLP1R, IAPP, GIPR | ALPI 1589/4885PKM 3342/4885PTGS1 2018/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.